NCIt definition : A formulation containing an androgen receptor (AR) antagonist with potential antineoplastic
activity. Darolutamide binds to ARs in target tissues; subsequently, inhibiting androgen-induced
receptor activation and facilitating the formation of inactive complexes that cannot
translocate to the nucleus. This prevents binding to and transcription of AR-responsive
genes that regulate prostate cancer cell proliferation. This ultimately leads to an
inhibition of growth in AR-expressing prostate cancer cells.;
UNII : X05U0N2RCO;
InChIKey : BLIJXOOIHRSQRB-PXYINDEMSA-N;
CAS number : 1297538-32-9; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1297538-32-9
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Drug name : Nubeqa;
Molecule name : ODM-201; BAY 1841788; BAY-1841788; ODM 201;